Submitted:
25 September 2025
Posted:
29 September 2025
You are already at the latest version
Abstract
Keywords:
1. Introduction
2. Materials and Methods
2.1. Description of the Trial Site and Hut Design
2.2. Description of the Test Product
2.3. Preparation of Nets and Washing Procedure
2.4. Cone Bioassays
2.5. Experimental Hut Trial
- Unwashed YAHE 4.0 LLIN
- Unwashed Interceptor® LLIN
- Unwashed DuraNet Plus
- YAHE 4.0 LLIN washed 20 times
- Interceptor® LLIN washed 20 times
- DuraNet Plus LLIN washed 20 times
- Untreated polyester net
- Deterrence (reduction in hut entry relative to the control huts fitted with untreated nets)
- Induced exiting (the proportion of mosquitoes that are found in exit traps and verandahs relative to control)
- Blood-feeding inhibition (the reduction in blood-feeding relative to the control)
- Mortality (the proportion of mosquitoes killed)
- Personal protection, which can be estimated by the calculation of:
- Personal protection (%) =100 (Bu – Bt)/Bu, where Bu is the total number of blood-fed in the huts with untreated nets, and Bt is the total number of blood-fed in the huts with LLIN-treated nets
- The overall killing effect of the treatment was estimated by the calculation:
2.6. WHO Insecticide Susceptibility Tests
2.7. Chemical Analysis
2.8. Data Analysis
3. Results
3.1. Cone Bioassay Tests Before the Hut Trial








3.2. Cone Bioassays After the Hut Trial
3.3. Hut Trial Results
3.3.1. Number of Mosquitoes Collected from Huts and Exiting Rates
3.3.2. Blood-Feeding
| Variables | Type of LLIN | ||||||
|---|---|---|---|---|---|---|---|
| Untreated | YAHE 4.0 | YAHE 4.0 | Interceptor | Interceptor | DuraNet Plus | DuraNet Plus | |
| No of washes | 0 | 0 | 20 | 0 | 20 | 0 | 20 |
| Total females caught | 374 | 343 | 326 | 492 | 709 | 287 | 370 |
| Mean females caught/night |
3.3 | 3.1 | 2.9 | 4.4 | 6.3 | 2.6 | 3.3 |
| Total females exited | 312 | 284 | 268 | 424 | 594 | 248 | 304 |
| % Exophily (95% CI) |
83.4 (79.6 – 87.1) |
82.8 (78.8 – 86.8) |
82.2 (78.1 – 86.4) |
86.2 (83.1 – 89.2) |
83.8 (81.1 – 86.5) |
86.4 (82.4 – 90.4) |
82.2 (78.3 – 86.1) |
| Total females blood fed | 171 | 110 | 107 | 188 | 216 | 101 | 167 |
| % Blood fed (95% CI) |
45.7 (40.6 – 50.8) |
32.1 (27.1 – 37.0) |
32.8 (27.7 – 37.9) |
38.2 (33.9 – 42.5) |
30.4 (27.1 – 33.8) |
35.2 (29.7 – 40.7) |
45.1 (40.1 – 50.2) |
| Blood feeding AOR (95% CI) P-value; z-value |
1.0 | 0.5 (0.3 – 0.7) < 0.000; -4.19 |
0.6 (0.4 – 0.8) 0.001; -3.22 |
0.7 (0.5 – 1.0) 0.044; -2.02 |
0.6 (0.5 – 0.8) 0.001; -3.28 |
0.6 (0.4 – 0.9) 0.009; -2.62 |
1.0 (0.7 – 1.3) 0.765; -0.30 |
| % Blood feeding inhibition | 0 | 29.9 | 28.2 | 16.4 | 33.4 | 23.0 | 1.3 |
| Total females dead | 17 | 159 | 162 | 238 | 313 | 155 | 206 |
| % Mortality (95% CI) |
4.5 (2.4 – 6.6) |
46.4 (41.1 – 51.6) |
49.7 (44.3 – 55.1) |
48.4 (44.0 – 52.8) |
44.1 (40.5 – 47.8) |
54.0 (48.2 – 59.8) |
55.7 (50.6 – 60.7) |
| Mortality AOR (95% CI) P-value; Z-value |
1 | 66.9 (22.7 – 197.4) < 0.000; 7.62 |
74.9 (25.4 – 220.9) < 0.000; 7.82 |
51.9 (17.7 – 151.8) < 0.000; 7.21 |
54.6 (18.7 – 159.1) < 0.000; 7.32 |
83.1 (27.9 – 247.1) < 0.000; 7.95 |
60.6 (20.6 – 178.3) < 0.000; 7.45 |
| % Overall killing effect | 0 | 38.0 | 38.8 | 59.1 | 79.1 | 36.9 | 50.5 |
| Outcome | Reference net | Candidate net | AOR | 95% CI (p-value, Z- value) |
Non inferiority margin |
Test outcome |
|---|---|---|---|---|---|---|
|
Primary: Mortality (72 hours) |
Unwashed Interceptor™ | Unwashed YAHE 4.0 | 0.66 | 0.48 – 0.92 (0.014, -2.47) |
1.33 | Non-inferior and superior |
| Washed Interceptor™ | Unwashed YAHE 4.0 | 0.93 | 0.68 – 1.27 (0.665, -0.43) |
1.37 |
Non-inferior and not superior | |
| Unwashed DuraNet Plus | Unwashed YAHE 4.0 | 0.78 | 0.54 – 1.13 (0.194, -1.30) |
1.34 |
Non-inferior and not superior | |
| Washed DuraNet Plus | Washed YAHE 4.0 | 0.64 | 0.47 – 0.85 (0.004, -2.91) |
1.32 |
Non – inferior and superior |
3.3.3. Mortality
| Outcome | Reference net | Candidate net | OR | 95% CI (p-value, Z- value) |
Non inferiority margin |
Target outcome | Test outcome |
|---|---|---|---|---|---|---|---|
|
Primary: Mortality (72 hours) |
Unwashed Interceptor™ | Unwashed YAHE 4.0 | 1.29 | 0.90 – 1.84 (0.161, 1.40) |
0.75 | Superiority | Non-inferior and not superior |
| Washed Interceptor™ | Unwashed YAHE 4.0 | 1.37 | 0.98 – 1.91 (0.061, 1.87) |
0.75 |
Superiority | Non-inferior and not superior | |
| Unwashed DuraNet Plus | Unwashed YAHE 4.0 | 0.80 | 0.54 – 1.20 (0.290, -1.06) |
0.76 |
Non-inferiority | Non-inferiority not shown | |
| Washed DuraNet Plus | Washed YAHE 4.0 | 1.24 | 0.86 – 1.78 (0.257, 1.13) |
0.76 |
Non-inferiority | Non – inferior and not superior |
3.4. WHO Susceptibility Tests


3.5. Chemical Analysis
| Active substance | Net sample condition (*) | Times washed | Mean a.s. content (g/kg) (n = 5) |
a.s. variation (RSD) (n = 5) |
a.s. retention (relative to content before washing) | Wash resistance index (%) |
|---|---|---|---|---|---|---|
| Alpha-cypermethrin | BHT | 0 wash | 8.70 | 4.4% | ||
| Whole net, 120 denier | BHT | 20 washes | 8.25 | 1.9% | 94.9% | 99.7% |
| AHT | 0 wash | 8.33 | 1.9% | |||
| AHT | 20 washes | 7.75 | 1.1% | 93.0% | 99.6% |
| Synergist | Net sample condition (*) | Times washed | Mean a.s. content (g/kg) (n = 5) |
a.s. variation (RSD) (n = 5) |
a.s. retention (relative to content before washing) | Wash resistance index (%) |
|---|---|---|---|---|---|---|
| Piperonyl butoxide | BHT | 0 wash | 3.46 | 2.5% | ||
| Whole net, 120 denier | BHT | 20 washes | 3.08 | 1.1% | 88.9% | 99.4% |
| AHT | 0 wash | 3.11 | 1.9% | |||
| AHT | 20 washes | 2.73 | 1.6% | 87.7% | 99.3% |
| Active substance | Net sample condition (*) | Times washed | Mean a.s. content (g/kg) (n = 5) |
a.s. variation (RSD) (n = 5) |
a.s. retention (relative to content before washing) | Wash resistance index (%) |
|---|---|---|---|---|---|---|
| Alpha-cypermethrin | BHT | 0 wash | 6.11 | 0.8% | ||
| Whole net, 150 denier | BHT | 20 washes | 5.53 | 1.0% | 90.5% | 99.5% |
| AHT | 0 wash | 5.91 | 2.3% | |||
| AHT | 20 washes | 5.55 | 2.5% | 93.9% | 99.7% |
| Synergist | Net sample condition (*) | Times washed | Mean a.s. content (g/kg) (n = 5) |
a.s. variation (RSD) (n = 5) |
a.s. retention (relative to content before washing) | Wash resistance index (%) |
|---|---|---|---|---|---|---|
| Piperonyl butoxide | BHT | 0 wash | 1.86 | 4.5% | ||
| Whole net, 150 denier | BHT | 20 washes | 1.66 | 3.0% | 89.2% | 99.4% |
| AHT | 0 wash | 1.71 | 4.6% | |||
| AHT | 20 washes | 1.61 | 3.5% | 93.9% | 99.7% |

4. Discussion
5. Study Limitation
6. Conclusions
Author contributions
Funding
Informed Consent Statement
Institutional Review Board Statement
Data Availability Statement
Acknowledgements
Competing interests
Abbreviations
| AOR | Adjusted odds ratio |
| CDC | Centers for Disease Control and Prevention |
| CI | Confidence Interval |
| IRS | Indoor residual spraying |
| ITNs | Insecticide treated nets |
| LLINs | Long-lasting insecticidal nets |
| NIM | Non-inferiority margin |
| NIMR | National Institute for Medical Research |
| PAMVERC | Pan African Malaria Vector Research Consortium |
| PBO | Piperonyl butoxide |
| RCTs | Randomized control trials |
| WHO | World Health Organization |
| WHOPES | World Health Organization Pesticides Evaluation Scheme |
| WHOPQT | World Health Organization Pre-qualification team |
References
- WHO. World Health Organization. World malaria report 2024: Addressing inequity in the global malaria response. Geneva: World Health Organization. 2024.
- WHO. World malaria World malaria report report 2023. Geneva: World Health Organization 2023. 283 p. Available from: https://www.wipo.int/amc/en/mediation/%0Ahttps://www.who.int/teams/global-malaria-programme/reports/world-malaria-report-2023.
- Bhatt, S.; Weiss, D.J.; Cameron, E.; Bisanzio, D.; Mappin, B.; Dalrymple, U.; Battle, K.E.; Moyes, C.; Henry, A.; Eckhoff, P.A. et al. The effect of malaria control on Plasmodium falciparum in Africa between 2000 and 2015. Nature. 2015, 526, 207–11. Available from: http://www.nature.com/articles/nature15535.
- Hancock, P.A.; Hendriks, C.J.M.; Tangena, J.-A.; Gibson, H.; Hemingway, J.; Coleman, M.; Gething, P.W.; Cameron, E.; Bhatt, S.; Catherine, L.; Moyes, C.L. Mapping trends in insecticide resistance phenotypes in African malaria vectors. PLoS Biol. 2020, 18, e3000633. [Google Scholar] [CrossRef] [PubMed]
- Matiya, D.J.; Philbert, A.B.; Kidima, W.; Matowo, J.J. Dynamics and monitoring of insecticide resistance in malaria vectors across mainland Tanzania from 1997 to 2017: a systematic review. Malar J. 2019, 18, 102. [Google Scholar] [CrossRef] [PubMed]
- Surendran, S.N.; Jayadas, T.T.P.; Thiruchenthooran, V.; Santhirasegaram, S.; Sivabalakrishnan, K.; Raveendran, S.; Ramasamy, R. Anopheline bionomics, insecticide resistance and transnational dispersion in the context of controlling a possible recurrence of malaria transmission in Jaffna city in northern Sri Lanka. Parasit Vectors. 2020, 13, 156. [Google Scholar] [CrossRef]
- Bartilol, B.; Omedo, I.; Mbogo, C.; Mwangangi, J.; Rono, M.K. Bionomics and ecology of Anopheles merus along the East and southern Africa coast Parasit. Vectors. 2021, 14, 84. [Google Scholar] [CrossRef]
- Soma, D.D.; Zogo, B.; Hien, D.F.d.; Hien, A.S.; Kabore, D.A.; Kientega, M.; Ouédraogo, A.G.; Pennetier, C.; Koffi, A.A.; Moiroux, N.; et al. Insecticide resistance status of malaria vectors Anopheles gambiae (s.l.) of southwest Burkina Faso and residual efficacy of indoor residual spraying with microencapsulated pirimiphos-methyl insecticide. Parasit Vectors. 2021, 14, 58. [Google Scholar] [CrossRef]
- Mosha, J.F.; Kulkarni, M.A.; Lukole, E.; Matowo, N.S.; Pitt, C.; Messenger, L.; Mallya, E.; Jumanne, M.; Aziz, T.; Kaaya, R.; et al. Effectiveness and cost-effectiveness against malaria of three types of dual-active-ingredient long-lasting insecticidal nets (LLINs) compared with pyrethroid-only LLINs in Tanzania: a four-arm, cluster-randomised trial. Lancet. 2022, 399, 1227–41. [Google Scholar] [CrossRef]
- Sovi, A.; Adoha, C.J.; Yovogan, B.; Cross, C.L.; Dee, D.P.; Konkon, A.K.; Sidick, A.; Accrombessi, M.; Ahouandjinou, M.J.; Osse, R.; et al. The effect of next-generation, dual-active-ingredient, long-lasting insecticidal net deployment on insecticide resistance in malaria vectors in Benin: results of a 3-year, three-arm, cluster-randomised, controlled trial. The Lancet Planetary Health. 2024, 8, e894–e905. [Google Scholar] [CrossRef]
- Bingham, G.; Strode, C.; Tran, L.; Khoa, P.T.; Jamet, H.P. Can piperonyl butoxide enhance the efficacy of pyrethroids against pyrethroid-resistant Aedes aegypti? Trop Med Int Health. 2011, 16, 492–500. [Google Scholar] [CrossRef]
- Gleave, K.; Lissenden, N.; Chaplin, M.; Choi, L.; Ranson, H. Piperonyl butoxide (PBO) combined with pyrethroids in insecticide- treated nets to prevent malaria in Africa. Cochrane Database of Systematic Reviews. 2021, 24. [Google Scholar] [CrossRef]
- Kleinschmidt, I.; Rowland, M. Insecticides and malaria. In: Koenraadt, C.J.M.; Spitzen, J.; Takken, W. editors. Innovative strategies for vector control- Ecology and control of vector-borne diseases [Internet]. Wageningen: Wageningen Academic Publishers; 2021, p. 17–32. Available from: https://www.wageningenacademic.com/doi/10.3920/978-90-8686-895-7_2.
- Protopopoff, N.; Mosha, J.F.; Lukole, E.; Charlwood, J.D.; Wright, A.; Mwalimu, C.D.; Manjurano, A.; Mosha, F.W; Kisinza, W.; Kleinschmidt, I.; et al. Effectiveness of a long-lasting piperonyl butoxide-treated insecticidal net and indoor residual spray interventions, separately and together, against malaria transmitted by pyrethroid-resistant mosquitoes:a cluster, randomised controlled, two-by-two factorial design trial. Lancet. 2018, 391, 1577–88. [Google Scholar]
- Staedke, S.G.; Gonahasa, S.; Dorsey, G.; Kamya, M.R.; Maiteki-Sebuguzi, C.; Lynd, A.; Katureebe, A.; Kyohere, M.; Mutungi, P.; Kigozi, S.P.; et al. Effect of long-lasting insecticidal nets with and without piperonylbutoxide on malaria indicators in Uganda (LLINEUP): a pragmatic, cluster-randomised trial embedded in a national LLIN distribution campaign. Lancet 2020, 395, 1292–303. [Google Scholar] [CrossRef]
- WHO. Prequalified vector control products. Geneva: World Health Organization. 2025. Available at https://extranet.who.int/prequal/vector-control-products/prequalified-product-list (Accessed on 2025 August 31).
- Oxborough, R. M.; Chilito, K. L. F.; Tokponnon, F.; Messenger, L.A. Malaria vector control in sub-Saharan Africa: complex trade-offs to combat the growing threat of insecticide resistance. The Lancet Planetary Health 2024, 8, e804–e812. [Google Scholar] [CrossRef] [PubMed]
- Mbewe, N.J.; Azizi, S.; Rowland, M.W.; Kirby, M.J.; Ezekia, K.; Manunda, B.; Shayo, M.F.; Portwood, N.M.; Mosha, F.W.; Matowo, J. Assessments of Anopheles arabiensis behaviour around bed nets using partial adhesive treatments. Sci. Rep., 2025, 15, 20966 1. [Google Scholar] [CrossRef] [PubMed]
- WHO. Conditions for Deployment of Mosquito Nets Treated With a Pyrethroid and Piperonyl Butoxide Geneva: World Health Organization Global Malaria Program. 2017.
- WHO. Test procedures for insecticide resistance monitoring in malaria vector mosquitoes. Geneva: World Health Organization. 2016. https://www.who.int/malaria/publications/atoz/9789241511575/en/ [Google Scholar.
- WHO. Technical consultation to assess comparative efficacy of vector control products: meeting report, 5 and 9 June 2023. Geneva: World Health Organization. 2023 (http://iris.who.int/handle/10665/372841, accessed 10 October 2023).
- Matowo, J.; Weetman, D.; Pignatelli, P.; Wright, A.; Charlwood, J.D.; Kaaya, R.; Shirima, B.; Moshi, O.; Lukole, E.; Mosha, J.; et al. Expression of pyrethroid metabolizing P450 enzymes characterizes highly resistant Anopheles vector species targeted by successful deployment of PBO-treated bednets in Tanzania. PLoS ONE. 2022, 17, e0249440. [Google Scholar] [CrossRef] [PubMed]
- N'Guessan, R.; Asidi, A.; Boko, P.; Odjo, A.; Akogbeto, M.; Pigeon, O.; Rowland, M. An experimental hut evaluation of PermaNet(®) 3.0, a deltamethrin-piperonyl butoxide combination net, against pyrethroid-resistant Anopheles gambiae and Culex quinquefasciatus mosquitoes in southern Benin. Trans R Soc Trop Med Hyg.2010, 104, 758-65. doi: 10.1016/j.trstmh.2010.08.008. Epub 2010 Oct 16. PMID: 20956008.
- Tungu, P.; Magesa, S.; Maxwell, C.; Malima, R.; Masue, D.; Sudi, W.; Myamba, J.; Pigeon, O.; Rowland, M. Evaluation of PermaNet 3.0 a deltamethrin-PBO combination net against Anopheles gambiae and pyrethroid resistant Culex quinquefasciatus mosquitoes: an experimental hut trial in Tanzania. Malar J. 2010, 9, 21. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Koudou, B.G.; Koffi, A.A.; Malone, D.; Hemingway, J. Efficacy of PermaNet® 2.0 and PermaNet® 3.0 against insecticide-resistant Anopheles gambiae in experimental huts in Côte d’Ivoire. Malar J. 2011, 10, 172. [Google Scholar] [CrossRef]
- Pennetier, C.; Bouraima, A.; Chandre, F.; Piameu, M.; Etang, J.; Rossignol, M.; Sidick, I.; Zogo, B.; Lacroix, M.-N.; Yadav, R.; et al. Efficacy of Olyset® Plus, a new long-lating insecticidal net incorporating permethrin and piperonyl-butoxide against multi-resistant malaria vectors. PLoS ONE. 2023, 8, e75134. [Google Scholar]
- Toe, K.H.; Müller, P.; Badolo, A.; Traore, A.; Sagnon, N.; Dabiré, R.K.; Ranson, H. Do bednets including piperonyl butoxide offer additional protection against populations of Anopheles gambiae s.l. that are highly resistant to pyrethroids? An experimental hut evaluation in Burkina Fasov. Med Vet Entomol. 2018, 32, 407–416. [Google Scholar] [CrossRef] [PubMed]
- WHO. Conditions for Deployment of Mosquito Nets Treated With a Pyrethroid and Piperonyl Butoxide Geneva: World Health Organisation Global Malaria Program,.2017.
- WHO. Guidelines for laboratory and field-testing of long-lasting insecticidal nets. Geneva: World Health Organization. 2013.https://apps.who.int/iris/handle/10665/80270 [Google Scholar].
- Matowo, J.; Kulkarni, MA.; Mosha, F.W.; Oxborough, R.M.; Kitau, J.; Tenu, F.; Rowland, M. Biochemical basis of permethrin resistance in Anopheles arabiensis from Lower Moshi, north-eastern Tanzania. Malar J. 2010, 9, 193. [Google Scholar] [CrossRef]
- Matowo, J.; Kitau, J.; Kabula, B.; Kavishe, R.A.; Oxborough, R.M.; Kaaya, R.; Francis, P.; Chambo, A.; Mosha, F.W.; Rowland, M. Dynamics of insecticide resistance and the frequency of kdr mutation in the primary malaria vector Anopheles arabiensis in rural villages of Lower Moshi, North Eastern Tanzania. J Parasitol and Vector BioloL. 2014, 6, 31–41. [Google Scholar]
- Oxborough, R.; Kiau, J.; Re Jones, R.; Feston, E.; Matowo, J.; Mosha F.W.; Rowland M. Long-Lasting Control of Anopheles arabiensis by a Single Spray Application of Microencapsulated Pirimiphos-methyl (Actellic(R) 300 CS) Mala J. 2014, 13, 37.
- Kitau J, Oxborough R, Kaye A, Chen-Hussey V, Isaacs E, Matowo J, Magesa SM, Mosha F, Rowland M and Logan J. Long-lasting insecticide treated blanket for protection against Anopheles arabiensis and Culex quinquefasciatus: an experimental hut evaluation in Tanzania Parasit Vectors 2014, 7, 129.
- Mosha, F.W.; Lyimo, I.N.; Oxborough, R.M.; Malima, R.; Tenu, F.; Matowo, J.; Feston, E.; Mndeme, R.; Magesa, S.M.; Rowland, M. Experimental evaluation of the pyrolle insecticide chlorfenapyr on bed nets for the control of Anopheles arabiensis and Culex quinquefasciatus. Trop Med & Inter Health. 2008, 13, 644–652. [Google Scholar]
- Mosha, F.W.; Lyimo, I.N.; Oxborough, R.M.; Matowo, J.; Malima, R.; Feston, E.; Mndeme, R.; Tenu, F.; Kulkarni, M.; Maxwell, C.A.; Magesa, S.M.; Rowland, M.W. Comparative efficacies of permethrin-, deltamethrin- and alpha-cypermethrin-treated nets, against Anopheles arabiensis and Culex quinquefasciatus in northern Tanzania. Ann Trop Med &Parasitol. 2008, 102, 367–76. [Google Scholar]
- Mahande, A.M.; Msangi, S.; Lyaruu, L.J.; Kweka, E.J. Bio-efficacy of DuraNet® long-lasting insecticidal nets against wild populations of Anopheles arabiensis in experimental huts. Trop. Med. Health. 2028, 46, 36. [Google Scholar] [CrossRef]
- Tungu, P.K.; Waweru, J.; Karthi, S.; Wangai, J.; Kweka, E.J. Field evaluation of Veeralin, an alpha-cypermethrin + PBO long-lasting insecticidal net, against natural populations of Anopheles funestus in experimental huts in Muheza, Tanzania. Curr Res Parasitol Vector Borne Dis. 2021, 1, 100030. [Google Scholar] [CrossRef]
- Clegban, C.M.Y.; Camara, S.; Koffi, A.A.; Ahoua Alou, L.P.; Kouame, J.K.; Koffi, A.F.; Kouassi, P.K.; Moiroux, N. Evaluation of Yahe® and Panda® 2.0 long-lasting insecticidal nets against wild pyrethroid-resistant Anopheles gambiae s.l. from Côte d’Ivoire: an experimental hut trial. Parasit Vectors. 2021, 14, 347. [Google Scholar] [CrossRef]
- Kweka, E.J.; Tungu, P.K.; Mahande, A.M.; Mazigo, H.D.; Sayumwe, S.; Msangi, S.; Lyaruu.; Waweru, J.; Kisinza, W.; Wangai, J. Bio-efficacy and wash resistance of MAGNet long-lasting insecticidal net against wild populations of Anopheles funestus in experimental huts in Muheza, Tanzania. Malar J. 2019, 18, 335. [CrossRef]
- Oumbouke, W.A.; Rowland, M.; Koffi, A.A.; Alou, L.A.; Camara, S.; NʼGuessan, R. Evaluation of an alpha-cypermethrin plus PBO mixture long-lasting insecticidal net VEERALIN® LN against pyrethroid resistant Anopheles gambiae s.s.: an experimental hut trial in M’be, central C^ote dʼIvoire. Parasit. Vectors. 2019, 12, 544. [Google Scholar] [CrossRef]
| LN type | LN status | No. of pieces to cut | No. pieces to test in Cones | No. of pieces for chemical analysis | Total pieces for chemical analysis/ LN type |
|---|---|---|---|---|---|
| DuraNet Plus | Before washing* | 5 | 5 | 5 | 20 |
| After 20 washes– before hut trial* | 5 | 5 | 5 | ||
| After hut trial - Olyset® Plus unwashed | 5 | 5 | 5 | ||
| After hut trial - Olyset® Plus washed 20X | 5 | 5 | 5 | ||
| Interceptor® LN | Before washing* | 5 | 5 | 5 | 20 |
| After 20 washes– before hut trial* | 5 | 5 | 5 | ||
| After hut trial - Interceptor® unwashed | 5 | 5 | 5 | ||
| After hut trial - Interceptor® washed 20X | 5 | 5 | 5 | ||
| YAHE 4.0 | Before washing* | 5 | 5 | 5 | 20 |
| After 20 washes– before hut trial* | 5 | 5 | 5 | ||
| After hut trial – YAHE 4.0 unwashed | 5 | 5 | 5 | ||
| After hut trial – YAHE 4.0 washed 20X | 5 | 5 | 5 | ||
| Total | 60 |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).